{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:51:26Z","timestamp":1794012686587,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:00:00Z","timestamp":1763251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00415-025-13504-3","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T18:50:32Z","timestamp":1763319032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The overlooked side of myasthenia gravis: the non-motor manifestations\u2014a comprehensive review"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-7863","authenticated-orcid":false,"given":"Christian","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,16]]},"reference":[{"issue":"11","key":"13504_CR1","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.3390\/jcm10112235","volume":"10","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med 10(11):2235. https:\/\/doi.org\/10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"13504_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.70309","author":"B Wang","year":"2025","unstructured":"Wang B, Liu D, Yang Y, Zhu R (2025) Beyond the surface: investigating the potential mechanisms of non\u2010motor symptoms in myasthenia gravis. Eur J Neurol. https:\/\/doi.org\/10.1111\/ene.70309","journal-title":"Eur J Neurol"},{"issue":"1","key":"13504_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12883-024-03644-w","volume":"24","author":"A Uzawa","year":"2024","unstructured":"Uzawa A et al (2024) Taste disorders and alopecia in myasthenia gravis. BMC Neurol 24(1):139. https:\/\/doi.org\/10.1186\/s12883-024-03644-w","journal-title":"BMC Neurol"},{"issue":"1","key":"13504_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1468-1331.2012.03713.x","volume":"20","author":"C Kabasawa","year":"2013","unstructured":"Kabasawa C, Shimizu Y, Suzuki S, Masuda M, Nagane Y, Utsugisawa K, Suzuki Y, Utsumi H, Fujihara K, Suzuki N, Uchiyama S (2013) Taste disorders in myasthenia gravis: a multicenter cooperative study. Eur J Neurol 20(1):205\u2013207. https:\/\/doi.org\/10.1111\/j.1468-1331.2012.03713.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"13504_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40136-022-00428-z","volume":"10","author":"JW Hsieh","year":"2022","unstructured":"Hsieh JW, Daskalou D, Macario S, Voruz F, Landis BN (2022) How to manage taste disorders. Curr Otorhinolaryngol Rep 10(4):385\u2013392. https:\/\/doi.org\/10.1007\/s40136-022-00428-z","journal-title":"Curr Otorhinolaryngol Rep"},{"issue":"10","key":"13504_CR6","doi-asserted-by":"publisher","first-page":"e45544","DOI":"10.1371\/journal.pone.0045544","volume":"7","author":"FE Leon-Sarmiento","year":"2012","unstructured":"Leon-Sarmiento FE, Bayona EA, Bayona-Prieto J, Osman A, Doty RL (2012) Profound olfactory dysfunction in myasthenia gravis. PLoS ONE 7(10):e45544. https:\/\/doi.org\/10.1371\/journal.pone.0045544","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"13504_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jns.2015.06.054","volume":"356","author":"H Tekeli","year":"2015","unstructured":"Tekeli H, Senol MG, Altundag A, Yalc\u0131nkaya E, Kendirli MT, Ya\u015far H, Salihoglu M, Saglam O, Cayonu M, Cesmeci E, Hummel T (2015) Olfactory and gustatory dysfunction in myasthenia gravis: a study in Turkish patients. J Neurol Sci 356(1\u20132):188\u2013192. https:\/\/doi.org\/10.1016\/j.jns.2015.06.054","journal-title":"J Neurol Sci"},{"key":"13504_CR8","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2025.0242","author":"HJ Han","year":"2025","unstructured":"Han HJ (2025) Olfactory dysfunction in patients with acetylcholine-receptor-antibody-positive myasthenia gravis. J Clin Neurol. https:\/\/doi.org\/10.3988\/jcn.2025.0242","journal-title":"J Clin Neurol"},{"key":"13504_CR9","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.m2022.0411","author":"T Hummel","year":"2023","unstructured":"Hummel T, Liu DT, M\u00fcller CA, Stuck BA, Welge-L\u00fcssen A, H\u00e4hner A (2023) Olfactory dysfunction: etiology, diagnosis, and treatment. Dtsch Arztebl Int. https:\/\/doi.org\/10.3238\/arztebl.m2022.0411","journal-title":"Dtsch Arztebl Int"},{"issue":"6","key":"13504_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cia2.12327","volume":"6","author":"N Sasaki","year":"2023","unstructured":"Sasaki N, Sawada Y (2023) A case of myasthenia gravis following alopecia areata. J Cutan Immunol Allergy 6(6):237\u2013240. https:\/\/doi.org\/10.1002\/cia2.12327","journal-title":"J Cutan Immunol Allergy"},{"issue":"3","key":"13504_CR11","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/12034754231168839","volume":"27","author":"C Sibbald","year":"2023","unstructured":"Sibbald C (2023) Alopecia areata: an updated review for 2023. J Cutan Med Surg 27(3):241\u2013259. https:\/\/doi.org\/10.1177\/12034754231168839","journal-title":"J Cutan Med Surg"},{"key":"13504_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/840364","volume":"2011","author":"Y Nishimoto","year":"2011","unstructured":"Nishimoto Y, Suzuki S, Utsugisawa K, Nagane Y, Shibata M, Shimizu T, Suzuki N (2011) Headache associated with myasthenia gravis: the impact of mild ocular symptoms. Autoimmune Dis 2011:1\u20134. https:\/\/doi.org\/10.4061\/2011\/840364","journal-title":"Autoimmune Dis"},{"issue":"6","key":"13504_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11916-018-0687-3","volume":"22","author":"O Tong","year":"2018","unstructured":"Tong O, Delfiner L, Herskovitz S (2018) Pain, headache, and other non-motor symptoms in myasthenia gravis. Curr Pain Headache Rep 22(6):39. https:\/\/doi.org\/10.1007\/s11916-018-0687-3","journal-title":"Curr Pain Headache Rep"},{"key":"13504_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000000953","author":"UK Dhand","year":"2021","unstructured":"Dhand UK (2021) New daily persistent headache-like presentation triggered by a sudden head drop in a patient with myasthenia gravis. Neurol Clin Pract. https:\/\/doi.org\/10.1212\/CPJ.0000000000000953","journal-title":"Neurol Clin Pract"},{"issue":"2","key":"13504_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/brainsci13020170","volume":"13","author":"S Iacono","year":"2023","unstructured":"Iacono S, Di Stefano V, Costa V, Schir\u00f2 G, Lupica A, Maggio B, Norata D, Pignolo A, Brighina F, Monastero R (2023) Frequency and correlates of mild cognitive impairment in myasthenia gravis. Brain Sci 13(2):170. https:\/\/doi.org\/10.3390\/brainsci13020170","journal-title":"Brain Sci"},{"issue":"3","key":"13504_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/1980-57642020dn14-030013","volume":"14","author":"A Ayres","year":"2020","unstructured":"Ayres A, Winckler PB, Jacinto-Scudeiro LA, Rech RS, Jotz GP, Olchik MR (2020) Cognitive performance in patients with Myasthenia Gravis: an association with glucocorticosteroid use and depression. Dement Neuropsychol 14(3):315\u2013323. https:\/\/doi.org\/10.1590\/1980-57642020dn14-030013","journal-title":"Dement Neuropsychol"},{"key":"13504_CR17","doi-asserted-by":"publisher","first-page":"104441.635","DOI":"10.1016\/j.nmd.2024.07.644","volume":"43","author":"A Marcassoli","year":"2024","unstructured":"Marcassoli A et al (2024) 502P Cognitive functioning in myasthenia gravis: an Italian cohort study. Neuromuscul Disord 43:104441.635. https:\/\/doi.org\/10.1016\/j.nmd.2024.07.644","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"13504_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4103\/0972-2327.156560","volume":"18","author":"Z Mao","year":"2015","unstructured":"Mao Z, Yin J, Lu Z, Hu X (2015) Association between myasthenia gravis and cognitive function: a systematic review and meta-analysis. Ann Indian Acad Neurol 18(2):131. https:\/\/doi.org\/10.4103\/0972-2327.156560","journal-title":"Ann Indian Acad Neurol"},{"key":"13504_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac018","author":"B Klaus","year":"2022","unstructured":"Klaus B et al (2022) Structural and functional brain alterations in patients with myasthenia gravis. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcac018","journal-title":"Brain Commun"},{"key":"13504_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neuroscience.2024.02.021","volume":"544","author":"X Zhou","year":"2024","unstructured":"Zhou X et al (2024) Neurometabolic and brain functional alterations associated with cognitive impairment in patients with myasthenia gravis: a combined 1H-MRS and fMRI study. Neuroscience 544:12\u201327. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.02.021","journal-title":"Neuroscience"},{"issue":"1","key":"13504_CR21","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.1038\/s41598-022-22078-3","volume":"12","author":"D Marbin","year":"2022","unstructured":"Marbin D, Piper SK, Lehnerer S, Harms U, Meisel A (2022) Mental health in myasthenia gravis patients and its impact on caregiver burden. Sci Rep 12(1):19275. https:\/\/doi.org\/10.1038\/s41598-022-22078-3","journal-title":"Sci Rep"},{"key":"13504_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2840","author":"J Nadali","year":"2023","unstructured":"Nadali J et al (2023) Prevalence of depression and anxiety among myasthenia gravis (MG) patients: a systematic review and meta\u2010analysis. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.2840","journal-title":"Brain Behav"},{"key":"13504_CR23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9184","author":"C Law","year":"2020","unstructured":"Law C, Flaherty CV, Bandyopadhyay S (2020) A review of psychiatric comorbidity in myasthenia gravis. Cureus. https:\/\/doi.org\/10.7759\/cureus.9184","journal-title":"Cureus"},{"issue":"1","key":"13504_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/ene.14057","volume":"27","author":"A Bogdan","year":"2020","unstructured":"Bogdan A, Barnett C, Ali A, AlQwaifly M, Abraham A, Mannan S, Ng E, Bril V (2020) Chronic stress, depression and personality type in patients with myasthenia gravis. Eur J Neurol 27(1):204\u2013209. https:\/\/doi.org\/10.1111\/ene.14057","journal-title":"Eur J Neurol"},{"issue":"9","key":"13504_CR25","doi-asserted-by":"publisher","first-page":"4691","DOI":"10.1007\/s10072-025-08240-5","volume":"46","author":"V Gasparini","year":"2025","unstructured":"Gasparini V, Mattavelli D, Pantoni L (2025) Delayed diagnosis of myasthenia gravis caused by concurrent anxiety symptoms. Neurol Sci 46(9):4691\u20134693. https:\/\/doi.org\/10.1007\/s10072-025-08240-5","journal-title":"Neurol Sci"},{"key":"13504_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2025.501925","author":"J Yan","year":"2025","unstructured":"Yan J et al (2025) Sleep disturbances in patients with myasthenia gravis: a cross-sectional study. Neurolog\u00eda. https:\/\/doi.org\/10.1016\/j.nrl.2025.501925","journal-title":"Neurolog\u00eda"},{"key":"13504_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.86.16_supplement.P3.132","author":"A Wang","year":"2016","unstructured":"Wang A, Le D, Goyal N, Mozaffar T, Chui L, Hungs M (2016) Sleep disturbances in patients with myasthenia gravis: a prospective study (P3.132). Neurology. https:\/\/doi.org\/10.1212\/WNL.86.16_supplement.P3.132","journal-title":"Neurology"},{"issue":"1","key":"13504_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/nsn.nsn_126_24","volume":"42","author":"Y Dede","year":"2025","unstructured":"Dede Y, Koskderelioglu A, Gedizlioglu M (2025) Sleep-related quality of life in patients with myasthenia gravis. Neurol Sci Neurophysiol 42(1):7\u201313. https:\/\/doi.org\/10.4103\/nsn.nsn_126_24","journal-title":"Neurol Sci Neurophysiol"},{"issue":"1","key":"13504_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s12325-023-02704-w","volume":"41","author":"S Dewilde","year":"2024","unstructured":"Dewilde S, Phillips G, Paci S, De Ruyck F, Tollenaar NH, Janssen MF (2024) The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population. Adv Ther 41(1):271\u2013291. https:\/\/doi.org\/10.1007\/s12325-023-02704-w","journal-title":"Adv Ther"},{"issue":"4","key":"13504_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.4103\/neurol-india.NI_562_17","volume":"72","author":"R Kumar","year":"2024","unstructured":"Kumar R, Nayak C, Nagappa M, Rao S, Sinha S, Taly AB (2024) Sleep in myasthenia gravis: a questionnaire-based study. Neurol India 72(4):801\u2013805. https:\/\/doi.org\/10.4103\/neurol-india.NI_562_17","journal-title":"Neurol India"},{"issue":"6","key":"13504_CR31","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1589\/jpts.27.2013","volume":"27","author":"EF Oliveira","year":"2015","unstructured":"Oliveira EF et al (2015) Sleep disorders in patients with myasthenia gravis: a systematic review. J Phys Ther Sci 27(6):2013\u20132018. https:\/\/doi.org\/10.1589\/jpts.27.2013","journal-title":"J Phys Ther Sci"},{"key":"13504_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1266862","author":"J Yan","year":"2023","unstructured":"Yan J et al (2023) Treatment of insomnia in myasthenia gravis\u2014a prospective study on non-benzodiazepine hypnotics in the treatment of myasthenia gravis patients with insomnia. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2023.1266862","journal-title":"Front Neurol"},{"issue":"04","key":"13504_CR33","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1055\/s-0044-1780502","volume":"17","author":"SG Iafigliola","year":"2024","unstructured":"Iafigliola SG et al (2024) Treatment approaches to myasthenia gravis and obstructive sleep apnea: case report. Sleep Sci 17(04):e466\u2013e469. https:\/\/doi.org\/10.1055\/s-0044-1780502","journal-title":"Sleep Sci"},{"issue":"4","key":"13504_CR34","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1017\/cjn.2022.63","volume":"50","author":"S Alnajjar","year":"2023","unstructured":"Alnajjar S, Idiaquez Rios JF, Fathi D, Liu G, Bril V (2023) Gastrointestinal dysmotility as the first manifestation of Myasthenia Gravis. Can J Neurol Sci\/J Can des Sci Neurol 50(4):640\u2013641. https:\/\/doi.org\/10.1017\/cjn.2022.63","journal-title":"Can J Neurol Sci\/J Can des Sci Neurol"},{"key":"13504_CR35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32553","author":"T Nagar","year":"2022","unstructured":"Nagar T, Ramakrishna JM, Khanna V, Turk I (2022) Predominant intractable nausea in the diagnosis of bulbar myasthenia gravis: a case study and review of literature. Cureus. https:\/\/doi.org\/10.7759\/cureus.32553","journal-title":"Cureus"},{"issue":"10","key":"13504_CR36","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1111\/jgh.16650","volume":"39","author":"J Finsterer","year":"2024","unstructured":"Finsterer J, Strobl W (2024) Gastrointestinal involvement in neuromuscular disorders. J Gastroenterol Hepatol 39(10):1982\u20131993. https:\/\/doi.org\/10.1111\/jgh.16650","journal-title":"J Gastroenterol Hepatol"},{"key":"13504_CR37","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143771","author":"M Camilleri","year":"2021","unstructured":"Camilleri M (2021) Gastrointestinal motility disorders in neurologic disease. J Clin Investig. https:\/\/doi.org\/10.1172\/JCI143771","journal-title":"J Clin Investig"},{"issue":"11","key":"13504_CR38","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00415-014-7465-x","volume":"261","author":"A Nikoli\u0107","year":"2014","unstructured":"Nikoli\u0107 A et al (2014) The presence of dysautonomia in different subgroups of myasthenia gravis patients. J Neurol 261(11):2119\u20132127. https:\/\/doi.org\/10.1007\/s00415-014-7465-x","journal-title":"J Neurol"},{"key":"13504_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1415615","author":"M Zawadka-Kunikowska","year":"2024","unstructured":"Zawadka-Kunikowska M, Cie\u015blicka M, Klawe JJ, Tafil-Klawe M, Ka\u017amierczak W, Rzepi\u0144ski \u0141 (2024) Frequency and severity of autonomic dysfunction assessed by objective hemodynamic responses and patient-reported symptoms in individuals with myasthenia gravis. Front Neurosci. https:\/\/doi.org\/10.3389\/fnins.2024.1415615","journal-title":"Front Neurosci"},{"issue":"8","key":"13504_CR40","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/nu14081647","volume":"14","author":"AY-K Thye","year":"2022","unstructured":"Thye AY-K et al (2022) Exploring the gut microbiome in myasthenia gravis. Nutrients 14(8):1647. https:\/\/doi.org\/10.3390\/nu14081647","journal-title":"Nutrients"},{"issue":"26","key":"13504_CR41","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.12998\/wjcc.v12.i26.5863","volume":"12","author":"PR Elmati","year":"2024","unstructured":"Elmati PR, Jagirdhar GSK, Surani S (2024) Cardiac implications in myasthenia gravis. World J Clin Cases 12(26):5863\u20135867. https:\/\/doi.org\/10.12998\/wjcc.v12.i26.5863","journal-title":"World J Clin Cases"},{"key":"13504_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijcme.2014.08.003","volume":"5","author":"P Shivamurthy","year":"2014","unstructured":"Shivamurthy P, Parker MW (2014) Cardiac manifestations of myasthenia gravis: a systematic review. IJC Metab Endocr 5:3\u20136. https:\/\/doi.org\/10.1016\/j.ijcme.2014.08.003","journal-title":"IJC Metab Endocr"},{"issue":"3","key":"13504_CR43","doi-asserted-by":"publisher","first-page":"329","DOI":"10.4103\/0972-2327.116912","volume":"16","author":"C Puneeth","year":"2013","unstructured":"Puneeth C, Chandra S, Yadav R, Sathyaprabha T, Chandran S (2013) Heart rate and blood pressure variability in patients with myasthenia gravis. Ann Indian Acad Neurol 16(3):329. https:\/\/doi.org\/10.4103\/0972-2327.116912","journal-title":"Ann Indian Acad Neurol"},{"issue":"13","key":"13504_CR44","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.3390\/jcm11133697","volume":"11","author":"M Zawadka-Kunikowska","year":"2022","unstructured":"Zawadka-Kunikowska M, Rzepi\u0144ski \u0141, Tafil-Klawe M, Klawe JJ, Zalewski P, S\u0142omko J (2022) Association of cardiac autonomic responses with clinical outcomes of myasthenia gravis: short-term analysis of the heart-rate and blood pressure variability. J Clin Med 11(13):3697. https:\/\/doi.org\/10.3390\/jcm11133697","journal-title":"J Clin Med"},{"key":"13504_CR45","doi-asserted-by":"publisher","first-page":"101043","DOI":"10.1016\/j.cont.2023.101043","volume":"7","author":"S Sinha","year":"2023","unstructured":"Sinha S et al (2023) Lower urinary tract dysfunction in uncommon neurological diseases, Part II: a report of the Neuro-urology Promotion Committee of the International Continence Society. Continence 7:101043. https:\/\/doi.org\/10.1016\/j.cont.2023.101043","journal-title":"Continence"},{"issue":"2","key":"13504_CR46","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000514825","volume":"13","author":"F Tateno","year":"2021","unstructured":"Tateno F, Sakakibara R, Aiba Y (2021) Lower urinary tract symptoms in myasthenia gravis. Case Rep Neurol 13(2):490\u2013498. https:\/\/doi.org\/10.1159\/000514825","journal-title":"Case Rep Neurol"},{"key":"13504_CR47","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.72553","author":"P Pereira","year":"2024","unstructured":"Pereira P, Coelho MM, Tiz\u00f3n S, Freixo S (2024) Lower urinary tract dysfunction in myasthenia gravis: a case report and literature review. Cureus. https:\/\/doi.org\/10.7759\/cureus.72553","journal-title":"Cureus"},{"issue":"1","key":"13504_CR48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/ane.13419","volume":"144","author":"AO Donskov","year":"2021","unstructured":"Donskov AO, Vinge L, Axelsen SM, Andersen H (2021) Overactive bladder in patients with myasthenia gravis\u2014a cross-sectional population-based study. Acta Neurol Scand 144(1):76\u201380. https:\/\/doi.org\/10.1111\/ane.13419","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"13504_CR49","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13256-023-04089-4","volume":"17","author":"A Harrison","year":"2023","unstructured":"Harrison A, Mudhar O, Yoo J, Rampal M (2023) Diplopia in a patient presenting with \u2018blurred vision\u2019: a case report. J Med Case Rep 17(1):402. https:\/\/doi.org\/10.1186\/s13256-023-04089-4","journal-title":"J Med Case Rep"},{"key":"13504_CR50","doi-asserted-by":"publisher","first-page":"577669","DOI":"10.1016\/j.jneuroim.2021.577669","volume":"358","author":"J Wang","year":"2021","unstructured":"Wang J, Yan C, Zhao Z, Chen H, Shi Z, Du Q, Zhang Y, Qiu Y, Lang Y, Kong L, Cai L, Zhou H (2021) Sexual dysfunction in patients with myasthenia gravis. J Neuroimmunol 358:577669. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577669","journal-title":"J Neuroimmunol"},{"key":"13504_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4245","author":"C Papadopoulos","year":"2021","unstructured":"Papadopoulos C, Papadimas GK (2021) Erectile dysfunction and reduced libido in a myasthenia gravis patient treated with methotrexate. Clin Case Rep. https:\/\/doi.org\/10.1002\/ccr3.4245","journal-title":"Clin Case Rep"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13504-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13504-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T15:29:44Z","timestamp":1765812584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13504-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["13504"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13504-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,16]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest or financial disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"764"}}